Pubblicazioni

Articoli scientifici pubblicati su riviste internazionali a nome del Dott. Fabio Artosi.

2025

Tildrakizumab as a potential option for early psoriatic arthritis in patients with metabolic comorbidities and psoriasis: a case series

Dermatology Practical & Conceptual, 2025DOI

2025

Tildrakizumab 200 mg: a step forward in psoriasis treatment with added metabolic benefits

Journal of Dermatological Treatment, 2025 (June)DOI

2025

The efficacy and safety of Upadacitinib in the treatment of paradoxical amicrobial pustulosis and alopecia induced by infliximab in a patient with Crohn's disease

JAAD Case Reports, 2025DOI

2025

Response to "The effect of daily sunscreen application on vitamin D: findings from the open-label, randomised, controlled Sun-D Trial

British Journal of Dermatology, 2025DOI

2025

Psoriasis severity, comorbidity burden, and biologic therapy: a multicenter observational study using the Charlson Comorbidity Index

Journal of Dermatological Treatment, 2025 (September)DOI

2025

Efficacy and Safety of Apremilast in Oncological Patients with Moderate-to-Severe Plaque Psoriasis: A 5 years Retrospective Observational Study

Clinical, Cosmetic and Investigational DermatologyDOI

2025

Challenging Clinical Therapeutic Approach to Urticarial Vasculitis: A Case Series

Journal of Clinical Medicine, 2025 (June)DOI

2025

Bimekizumab for the treatment of moderate to severe psoriasis: a real-world experience over 52 weeks from two Italian dermatology clinics

Journal of Dermatological Treatment, 36(1), 2432932DOI

2025

A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes

Journal of Clinical Medicine, 2025DOI

2024

Role of Nicotinamide in the Pathogenesis of Actinic Keratosis: Implications for NAD+/SIRT1 Pathway

Biomolecules, 14(12), 1512DOI